<< Вернуться к списку статей журнала

Том 14 №2 2012 год - Нефрология и диализ

Наследственные митохондриальные цитопатии: коэнзим Q нефропатии (Обзор литературы)

Вашурина Т.В. Зробок О.И. Маргиева Т.В. Цыгин А.Н.

Аннотация: В обзоре представлены современные данные о крайне редких СoQ -дефицитных гломерулопатиях, как изолированных, так и в рамках мультисистемных инфантильных форм. Установление вторичности стероид-резистентного нефротического синдрома по отношению к дефициту коэнзима Q не представляется возможным без установления генетических дефектов его биосинтеза. Тем не менее, объединяющим ультраструктурным признаком гломерулярного повреждения, вторичного к наследственной митохондриальной дисфункции, является обнаружение распространенной пролиферации дисморфных митохондрий в подоцитах, эндотелиальных и мезангиальных клетках. Ранняя постановка диагноза имеет решающее значение, вследствие возможной чувствительности СoQ-дефицитных форм стероид-резистентного нефротического синдрома к введению коэнзима Q .

Для цитирования: Вашурина Т.В., Зробок О.И., Маргиева Т.В., Цыгин А.Н. Наследственные митохондриальные цитопатии: коэнзим Q нефропатии (Обзор литературы). Нефрология и диализ. 2012. 14(2):95-101. doi:

Весь текст

Ключевые слова: CoQ -нефропатия, CoQ -нефропатия, стероид-резистентный нефротический синдром, CoQ nephropathy, CoQ nephropathy, steroid-resistant nephrotic syndrome

Список литературы:

1. Abu-Amero K.K., Bosley T.M. Mitochondrial abnormalities in patients with LHON-like optic neuropathies // Invest. Ophthalmol. Vis. Sci. 2006. Vol. 47. P. 4211–4220.
2. Barisoni L., Kopp J.B. Modulation of podocyte phenotype in collapsing glomerulopathies // Microsc. Res. Tech. 2002. Vol. 57. P. 254–262.
3. Barisoni L., Madaio M.P., Eraso M. et al. The kd/kd mouse is a model of collapsing glomerulopathy // J. Am. Soc. Nephrol. 2005. Vol. 16. P. 2847–2851.
4. Bhagavan H.N., Chopra R.K. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics // Free Radic. Res. 2006. Vol. 40. P. 445–453.
5. Carelli V., La Morgia C., Valentino M.L. et al. Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders // Biochim. Biophys. Acta. 2009. Vol. 1787. P. 518–528.
6. Chinnery P.F., DiMauro S., Shanske S. et al. Risk of developing a mitochondrial DNA deletion disorder // Lancet. 2004. Vol. 364. P. 592–596.
7. Dallner G., Sindelar P.J. Regulation of ubiquinone metabolism // Free Radic. Biol. Med. 2000. Vol. 29. P. 285–294.
8. Degli-Esposti M., Ngo A., Ghelli A. et al. The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria // Arch. Biochem. Biophys. 1996. Vol. 330. P. 395–400.
9. Di Giovanni S., Mirabella M., Spinazzola A. et al. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency // Neurology. 2001. Vol. 57. P. 515–518.
10. DiMauro S., Quinzii C.M., Hirano M. Mutations in coenzyme Q10 biosynthetic genes // J. Clin. Invest. 2007. Vol. 117. № 3. P. 587–589.
11. Dimmer K.S., Rapaport D. Proteomic view of mitochondrial function // Genome Biol. 2008. Vol. 9. P. 209.
12. Diomedi-Camassei F., Di Giandomenico S. et al. COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement // J. Am. Soc. Nephrol. 2007. Vol. 18. P. 2773–2780.
13. Do T.Q., Hsu A.Y., Jonassen T. et al. A defect in coenzyme Q biosynthesis is responsible for the respiratory deficiency in Saccharomyces cerevisiae abc1 mutants // J. Biol. Chem. 2001. Vol. 276. P. 18161–18168.
14. Duncan A.J., Bitner-Glindzicz M., Meunier B. et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: a potentially treatable form of mitochondrial disease // Am. J. Hum. Genet. 2009. Vol. 84. P. 558–566.
15. Ernster L., Ikkos D., Luft R. Enzymic activities оf human skeletal muscle mitochondria: a tool in clinical metabolic research // Nature. 1959. Vol. 184. P. 1851–1854.
16. Eviatar L., Shanskce S., Gauthier B. et al. Kearns-Sayre syndrome presenting as renal tubular acidosis // Neurology. 1990. Vol. 40 P. 1761.
17. Finsterer J. Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation // Acta Neurol. Scand. 2007. Vol. 116. P. 1–14.
18. Finsterer J. Leigh and Leigh-like syndrome in children and adults // Pediatr. Neurol. 2008. Vol. 39. P. 223–235.
19. Fontaine E., Ichas F., Bernardi P. A ubiquinone-binding site regulates the mitochondrial permeability transition pore // J. Biol. Chem. 1998. Vol. 273. P. 25734–25740.
20. Genova M.L., Merlo-Pich M., Biondi A. et al. Mitochondrial production of oxygen radical species and the role of coenzyme Q as an antioxidant // Exp. Biol. Med. 2003. Vol. 228. P. 506–513.
21. Geromel V., Darin N., Chretien D. et al. Coenzyme Q(10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits // Mol. Genet. Metab. 2002. Vol. 77. P. 21–30.
22. Gilbert R.D., Emms M. Pearson's syndrome presenting with Fanconi syndrome // Ultrastr. Pathol. 1996. Vol. 20. P. 473–475.
23. Giulivi C. Characterization and function of mitochondrial nitricoxide synthase // Free Radic. Biol. Med. 2003. Vol. 34. P. 397–408.
24. Green D.R. Apoptotic pathways: ten minutes to dead // Cell. 2005. Vol. 121. № 5. P. 671–674.
25. Haas R.H., Parikh S., Falk M.J. et al. Mitochondrial disease: a practical approach for primary care physicians // Pediatrics. 2007. Vol. 120. P. 1326–1333.
26. Haas R.H., Parikh S., Falk M.J. et al. The in-depth evaluation of suspected mitochondrial disease // Mol. Genet. Metab. 2008. Vol. 94. P. 16–37.
27. Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system // Annu. Rev. Biochem. 1985. Vol. 54. P. 1015–1069.
28. Heeringa S.F., Chernin G., Chaki M. et al. COQ6 mutations in human patients produce nephritic syndrome with sensorineural deafness // J. Clin. Invest. 2011. Vol. 121. № 5. P. 2013–2024.
29. Hirano M., Konishi K., Arata N. et al. Renal complication in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA // Intern. Med. 2002. Vol. 41. P. 113–118.
30. Horvath R., Schneiderat P., Schoser B.G. et al. Coenzyme Q10 deficiency and isolated myopathy // Neurology. 2006. Vol. 66. P. 253–255.
31. Hott O., Inoue C.N., Miyabayashi S. et al. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation // Kidney Int. 2001. Vol. 59. P. 1236–1243.
32. Jacobs H.T., Turnbull D.M. Nuclear genes and mitochondrial translation: a new class of genetic disease // Trends Genet. 2005. Vol. 21. P. 312–314.
33. Johns D.R., Neufeld M.J. Cytochrome b mutations in Leber hereditary optic neuropathy. Biochem. Biophys. Res. Commun. 1991. Vol. 181. P. 1358–1364.
34. Kawamukai M. Biosynthesis and bioproduction of coenzyme Q10 by yeasts and other organisms // Biotechnol. Appl. Biochem. 2009. Vol. 53. P. 217–226.
35. Kim I., Rodriguez-Enriquez S., Lemasters J.J. Selective degradation of mitochondria by mitophagy // Arch. Biochem. Biophys. 2007. Vol. 462. № 2. P. 245–253.
36. King M.S, Sharpley M.S, Hirst J. Reduction of hydrophilic ubiquinones by the flavin in mitochondrial NADH:ubiquinone oxidoreductase (Complex I) and production of reactive oxygen species // Biochemistry. 2009. Vol. 48. P. 2053–2062.
37. Kitano A., Nishiyama S., Miike T. et al. The mitochondrial cytopathy with lactic acidosis, carnitin deficiency and De Toni–Debre–Fanconi syndrome // Brain. Dev. 1986. Vol. 8. № 3. P. 289–295.
38. Lagier-Tourenne C., Tazir M., Lopez L.C. et al. ADCK3, an ancestral kinase, is mutated in a form of recessive ataxia associated with coenzyme Q10 deficiency // Am. J. Hum. Genet. 2008. Vol. 82. P. 661–672.
39. Lalani S.R., Vladutiu G.D., Plunkett K. et al. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency // Arch. Neurol. 2005. Vol. 62. P. 317–320.
40. Lamperti C., Naini A., Hirano M. et al. Cerebellar ataxia and coenzyme Q10 deficiency // Neurology. 2003. Vol. 60. P. 1206–1208.
41. Lee H.F., Lee H.J., Chi C.S. et al. The neurological evolution of Pearson syndrome: case report and literature review // Eur. J. Paediatr. Neurol. 2007. Vol. 11. P. 208–214.
42. Lee W.K, Thevenod F. A role for mitochondrial aquaporins in cellular life-and-death decisions // Am. J. Physiol. Cell Physiol. 2006. Vol. 291. P. 195–202.
43. Lenaz G., Genova M.L. Structure and organization of mitochondrial respiratory complexes: a new understanding of an old subject // Antioxid. Redox Signal. 2010. Vol. 12. P. 961–1008.
44. Lopez L.C, Schuelke M., Quinzii C.M. et al. Leigh syndrome with nephropathy and CoQ10 deficiency due to decaprenyl diphosphate synthase subunit 2 (PDSS2) mutations // Am. J. Hum. Genet. 2006. Vol. 79. P. 1125–1129.
45. Lopez-Gallardo E., Lopez-Perez M.J., Montoya J. et al. CPEO and KSS differ in the percentage and location of the mtDNA deletion // Mitochondrion. 2009. Vol. 9. P. 314–317.
46. Lopez-Martin J.M, Salviati L., Trevisson E. et al. Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis // Hum. Mol. Genet. 2007. Vol. 16. P. 1091–1097.
47. Luft R., Ikkos D., Palmieri G., Ernster L. et al. A case of severe hypermetabolism of non-thyroid origin with a defect in the maintenance of mitochondrial respiratory control: a correlated clinical, biochemical, and morphological study // J. Clin. Ivest. 1962. Vol. 41. P. 1776–1804.
48. Ma Y., Fang F., Yang Y., Zou L. et al. The study of mitochondrial A3243G mutation in different samples // Mitochondrion. 2009. Vol. 9. P. 139–143.
49. Maceluch J.A., Niedziela M. The clinical diagnosis and molecular genetics of Kearns-Sayre syndrome: a complex mitochondrial encephalomyopathy // Pediatr. Endocrinol. Rev. 2006. Vol. 4. P. 117–137.
50. Madaio M.P, Ahima R.S, Meade R. et al. Glomerular and tubular epithelial defects in kd/kd mice lead to progressive renal failure // Am. J. Nephrol. 2005. Vol. 25. P. 604–610.
51. McFarland R., Turnbull D.M. Batteries not included: diagnosis and management of mitochondrial disease // J. Intern. Med. 2009. Vol. 265. P. 210–228.
52. Miles M.V. The uptake and distribution of coenzyme Q10 // Mitochondrion. 2007. Vol. 7 (Suppl). S 72–77.
53. Mochizuki H., Joh K., Kawame H. et al. Mitochondrial encephalomyopathies preceded by de Toni–Debre–Fanconi syndrome or focal segmental glomerulosclerosis // Source Clin. Nephrol. 1996. Vol. 46. № 5. P. 347–352.
54. Mollet J., Giurgea I., Schlemmer D. et al. Prenyldiphosphate synthase, subunit 1 (PDSS1) and OH-benzoate polyprenyltransferase (CoQ2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders // J. Clin. Invest. 2007. Vol. 117. P. 765–772.
55. Montero R., Artuch R., Briones P. et al. Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders // Biofactors. 2005. Vol. 25. P. 109–115.
56. Montini G., Malaventura C., Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency // N. Engl. J. Med. 2008. Vol. 358. P. 2849–2850.
57. Moser C.C., Farid T.A., Chobot S.E. et al. Electron tunneling chains of mitochondria // Biochim. Biophys. Acta. 2006. Vol. 1757. P. 1096–1109.
58. Munnich A., Rustin P. Clinical spectrum and diagnosis of mitochondrial disorders // Am. J. Med. Genet. 2001. Vol. 106. P. 4–17.
59. Murphy M.P. How mitochondria produce reactive oxygen species // Biochem. J. 2009. Vol. 417. P. 1–13.
60. Musumeci O., Naini A., Slonim A.E. et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency // Neurology. 2001. Vol. 56. P. 849–855.
61. Niaudet P. Mitochondrial disorders and the kidney // Arch. Intern. Med. 1998. Vol. 78. P. 387–390.
62. Niaudet P., Heidet L., Munnicb A. et al. Deletion of the mitochondrial DNA in a case of de Toni–Debre–Fanconi syndrome and Pearson's syndrome // Pediatr. Nephrol. 1994. Vol. 8. P. 164–168.
63. Niklowitz P., Menke T., Andler W. et al. Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults // Clin. Chim. Acta. 2004. Vol. 342. P. 219–226.
64. Ogasahara S., Engel A.G., Frens D. et al. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy // Proc. Natl. Acad. Sci. USA. 1989. Vol. 86. P. 2379–2382.
65. Peng M., Falk M.J., Haase V.H. et al. Primary coenzyme Q deficiency in Pdss2 mutant mice causes isolated renal disease // PLoS Genet. 2008. Vol. 4. № 4. P. 1–14.
66. Peng M., Jarett L., Meade R. et al. Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice // Kidney Int. 2004. Vol. 66. P. 20–28.
67. Perucca-Lostanlen D., Narbonne H., Hernandez J.B. et al. Mitochondrial DNA variations in patients with maternally inherited diabetes and deafness syndrome // Biochem. Biophys. Res. Commun. 2000. Vol. 3. P. 771–775.
68. Poyton R.O., Ball K.A., Castello P.R. Mitochondrial generation of free radicals and hypoxic signaling // Trends Endocrinol. Metab. 2009. Vol. 20. P. 332–340.
69. Poyton R.O., Castello P.R., Ball K.A. et al. Mitochondria and hypoxic signaling: a new view // Ann. NY Acad. Sci. 2009. Vol. 1177 P. 48–56.
70. Quinzii C.M., Hirano M. Coenzyme Q and mitochondrial disease // Dev. Disabil. Res. Rev. 2010. Vol. 16. № 2. P. 183–188.
71. Quinzii C.M, López L.C., Naini A. et al. Human CoQ10 deficiencies // Biofactors. 2008a. Vol. 32. P. 113–118.
72. Quinzii C.M, Lopez L.C., Von-Moltke J. et al. Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency // FASEB J. 2008b. Vol. 22. P. 1874–1885.
73. Quinzii C., Naini A., Salviati L. et al. A Mutation in para-hydroxybenzoate-polyprenyl transferase (COQ2) causes primary coenzyme Q10 deficiency // Am. J. Hum. Genet. 2006. Vol. 78. P. 345–349.
74. Rahman S., Hanna M.G. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases // J. Neurol. Neurosurg. Psychiatry. 2009. Vol. 80. P. 943–953.
75. Rodríguez-Hernández A., Cordero M.D., Salviati L. et al. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy // Autophagy. 2009. Vol. 5. P. 19–32.
76. Rotig A. Genetic bases of mitochondrial respiratory chain disorders // Diabetes Metab. 2010. Vol. 36. P. 97–107.
77. Rotig A. Renal disease and mitochondrial genetics // J. Nephrol. 2003. Vol. 16. P. 286–292.
78. Rotig A., Appelkvist E.L., Geromel V. et al. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency // Lancet. 2000. Vol. 356. P. 391–395.
79. Rotig A., Cormier V., Blanche S. et al. Pearson’s marrow-pancreas syndrome. A multisystem mitochondrial disorder in infancy // J. Clin. Invest. 1990. V. 86. P. 1601–1608.
80. Ruiz-Romeo C., Blanco F.J. Mitochondrial proteomics and its application in biomedical research // Mol. BioSyst. 2009. Vol. 5. P. 1130–1142.
81. Saiki R., Lunceford A.L., Shi Y. et al. Coenzyme Q10 supplementation rescues renal disease in Pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2 // Am. J. Physiol. Renal. Physiol. 2008. Vol. 295. P. 1535–1544.
82. Salviati L., Sacconi S., Murer L. et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition // Neurology. 2005. Vol. 65. P. 606–608.
83. Silvestri G., Ciafaloni E., Santorelli F.M. et al. Clinical features associated with the A->G transition at nucleotide 8344 of mtDNA (“MERRF mutation”) // Neurology. 1993. V. 43. P. 1200–1206.
84. Sue C.M., Quigley A., Katsabanis S. et al. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles // J. Neurol. Sci. 1998. Vol. 161. P. 36–39.
85. Taylor R.W., Schaefer A.M., Barron M.J., McFarland R., Turnbull D.M. The diagnosis of mitochondrial muscle disease // Neuromuscul. Disord. 2004. Vol. 14. P. 237–245.
86. Tran U.C., Clarke C.F. Endogenous synthesis of coenzyme Q in eukaryotes // Mitochondrion. 2007. Vol. 7 (Suppl). S. 62–71.
87. Turunen M., Olsson J., Dallner G. Metabolism and function of coenzyme Q // Biochim. Biophys. Acta. 2004. Vol. 1660. P. 171–199.
88. Valnot I., Kassis J., Chretien D. et al. A mitochondrial cytochrome b mutation but no mutations of nuclearly encoded subunits in ubiquinol cytochrome c reductase (complex III) deficiency // Hum. Genet. 1999. Vol. 104. P. 460–466.
89. van Goethem G., Martin J.J., van Broeckhoven C. Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification // Neuromolecular. Med. 2003. Vol. 3. P. 129–146.
90. Villalba J.M., López-Lluch G., Santos-Ocaña C. et al. Extramitochondrial functions of coenzyme Q// In: Boca Raton FL // Kagan V.E., Quinn P.J. editors. CRC Press. 2001. P. 83–98.
91. Waldmeier P.C, Zimmermann K., Qian T. et al. Cyclophilin D as a drug target // Curr. Med. Chem. 2003. Vol. 10. № 16. P. 1485–1506.
92. Walter L., Miyoshi H., Leverve X. et al. Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report // Free Radic. Res. 2002. Vol. 36. P. 405–412.
93. Wharram B.L., Goyal M., Wiggins J.E. et al. Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene // J. Am. Soc. Nephrol. 2005. Vol. 16. P. 2941–2952.
94. Wilson M.R. Apoptosis: unmasking the executioner // Cell Death Differ. 1998. Vol. 5. № 8. P. 646–652.
95. Wittig I., Carrozzo R., Santorelli F.M. et al. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation // Biochim. Biophys. Acta. 2006. Vol. 1757. P. 1066–1072.
96. Yu-Wai-Man P., Griffiths P.G., Hudson G. et al. Inherited mitochondrial optic neuropathies // J. Med. Genet. 2009. Vol. 46. P. 145–158.
97. Zhu X., Peng X., Guan M.X. et at. Pathogenic mutations of nuclear genes associated with mitochondrial disorders // Acta Biochim. Biophys. Sin. 2009. Vol. 41. P. 179–187.

Другие статьи по теме

• Редкая форма митохондриопатии, обусловленной дефицитом коэнзима Q: стероид-резистентный нефротический синдром вследствие мутации СoQ
• Клинико-генетическая гетерогенность cтероид-резистентного нефротического синдрома у детей (Обзор литературы)
• Клинические практические рекомендации IPNA по диагностике и лечению детей со стероид-резистентным нефротическим синдромом
• Исследование генетических причин врожденного и инфантильного нефротического синдрома у российских детей